Role of immunosuppressive drugs for prevention of graft-v-host disease after human HLA matched bone marrow transplantation.
Gluckman
E
E
Department of Hematology, Hôpital St Louis, Paris, France.
Devergie
A
A
Lokiec
F
F
Traineau
R
R
Cosset
J M
JM
Lemercier
N
N
Varrin
F
F
Cavazzana
M
M
de Castro
H
H
Meletis
J
J
D001853:Bone Marrow / Q000276:immunology; D016026:Bone Marrow Transplantation; D002469:Cell Separation; D003524:Cyclosporins / Q000627:therapeutic use; D006086:Graft vs Host Disease / Q000517:prevention & control*; D006680:HLA Antigens / Q000032:analysis; D006801:Humans; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008727:Methotrexate / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000166:cytology
D003524:Cyclosporins; D006680:HLA Antigens; D007166:Immunosuppressive Agents; D008727:Methotrexate